Your search for "Sogeval acquisition" return 17 results.
CEVA EXPANDS ORAL RABIES VACCINE PORTFOLIO WITH THE ACQUISITION OF CANADIAN FIRM ARTEMIS TECHNOLOGIES, INC. >
Libourne, May 16, 2022 – Ceva Santé Animale (Ceva) has acquired the Canadian oral rabies vaccine manufacturer Artemis Technologies, Inc. Artemis, located in Guelph, ON, Canada, produces ONRAB®, a ra...
Consolidated sales of the Ceva Group reached more than €1.2 billion in 2019.
2016 was a year of sustained organic growth and major acquisitions. Consolidated sales reached €912m.
Sales grew in all zones and across all species
Ceva Animal Health’s integration of Sogeval Laboratories is strengthening the company’s ability to provide total pet health solutions to veterinarians and their clients.
In connection with a trademark infringement lawsuit brought by PSPC, Inc. against Sogeval Laboratories, Inc. in the United State District Court for the Middle District of Florida, the parties have ent...
Ceva Animal Health has acquired Sogeval, a subsidiary of Sofiprotéol, solidifying Ceva’s position as a Top 10 global animal health company.
French veterinary pharmaceutical companies Ceva Santé Animale (Ceva), based in Libourne, and Sogeval (a subsidiary of Sofiprotéol), based in Laval have entered into exclusive merger negotiations.
Vector vaccine protects agains both Infectious Laryngotracheitis and Marek's disease
Update on Ceva's growth in North America